KIMBERLY BIRTCHER

Concepts (164)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cardiology
23
2023
478
2.220
Why?
Cardiovascular Diseases
18
2022
1890
1.620
Why?
American Heart Association
18
2023
299
1.520
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
11
2022
723
1.160
Why?
Hyperlipidemias
7
2022
173
1.020
Why?
Research Report
5
2021
70
0.850
Why?
Anticholesteremic Agents
8
2022
234
0.810
Why?
Primary Prevention
2
2021
166
0.790
Why?
Chest Pain
5
2021
124
0.760
Why?
Practice Guidelines as Topic
9
2021
1264
0.750
Why?
Platelet Aggregation Inhibitors
2
2020
261
0.710
Why?
Cholesterol
5
2021
532
0.660
Why?
Societies, Medical
6
2021
683
0.620
Why?
Aspirin
1
2020
222
0.610
Why?
Consensus
13
2024
629
0.600
Why?
Cholesterol, LDL
7
2022
560
0.600
Why?
Medication Adherence
5
2022
401
0.550
Why?
Drug-Related Side Effects and Adverse Reactions
2
2019
256
0.520
Why?
Secondary Prevention
3
2021
215
0.510
Why?
Ezetimibe
4
2022
95
0.490
Why?
Advisory Committees
5
2019
150
0.480
Why?
United States
31
2024
10775
0.460
Why?
Evidence-Based Medicine
5
2021
628
0.430
Why?
Hypercholesterolemia
4
2018
227
0.430
Why?
Dyslipidemias
3
2024
229
0.390
Why?
Algorithms
4
2021
1612
0.370
Why?
Atherosclerosis
4
2022
841
0.350
Why?
Coronary Artery Disease
4
2021
755
0.350
Why?
Diabetes Mellitus
3
2022
853
0.340
Why?
Awards and Prizes
1
2010
64
0.330
Why?
Hypertension
3
2022
1282
0.330
Why?
Coronary Disease
2
2010
652
0.310
Why?
Quality Assurance, Health Care
1
2010
208
0.310
Why?
Myocardial Infarction
2
2010
1011
0.310
Why?
Guideline Adherence
2
2010
377
0.300
Why?
Risk Reduction Behavior
4
2021
138
0.290
Why?
Diabetes Mellitus, Type 2
3
2024
1244
0.280
Why?
Heart Valve Diseases
2
2021
169
0.280
Why?
Humans
50
2025
124409
0.260
Why?
Registries
3
2021
1410
0.250
Why?
Medication Therapy Management
3
2018
25
0.220
Why?
Hypoglycemic Agents
2
2024
437
0.220
Why?
Hypolipidemic Agents
2
2008
179
0.210
Why?
Aged
12
2025
19481
0.210
Why?
Aortic Diseases
2
2023
201
0.210
Why?
Risk Factors
9
2021
10150
0.210
Why?
Risk Assessment
7
2021
3382
0.190
Why?
Cardiovascular System
1
2022
102
0.190
Why?
Military Medicine
1
2021
49
0.180
Why?
Diet Therapy
1
2021
41
0.180
Why?
Heart Valves
1
2021
51
0.180
Why?
Nutrition Policy
1
2021
100
0.180
Why?
Expert Testimony
1
2020
36
0.170
Why?
Lipids
2
2022
513
0.170
Why?
Hypertriglyceridemia
1
2021
102
0.170
Why?
Social Determinants of Health
1
2021
122
0.160
Why?
Cardiomyopathy, Hypertrophic
1
2021
152
0.160
Why?
Deprescriptions
1
2019
12
0.160
Why?
Inappropriate Prescribing
1
2019
41
0.160
Why?
Aging
1
2025
1184
0.150
Why?
Emergency Service, Hospital
2
2021
1088
0.140
Why?
Hemorrhage
1
2020
463
0.130
Why?
Heart Valve Prosthesis Implantation
1
2021
438
0.130
Why?
Consensus Development Conferences as Topic
1
2016
39
0.130
Why?
Cholesterol, HDL
2
2010
350
0.130
Why?
Pharmacy Service, Hospital
1
2015
49
0.120
Why?
Lower Extremity
1
2017
186
0.120
Why?
Pharmacists
1
2015
84
0.120
Why?
Tachycardia, Supraventricular
1
2015
108
0.110
Why?
Anticoagulants
2
2015
586
0.110
Why?
Retrospective Studies
8
2024
16232
0.110
Why?
ST Elevation Myocardial Infarction
1
2016
108
0.110
Why?
Disease Management
2
2015
519
0.110
Why?
Female
11
2024
66307
0.110
Why?
Coronary Angiography
1
2016
427
0.110
Why?
Middle Aged
6
2024
26461
0.110
Why?
Biomarkers
5
2021
2980
0.110
Why?
Peripheral Arterial Disease
1
2017
285
0.110
Why?
Health Policy
1
2015
212
0.100
Why?
Postal Service
1
1992
9
0.100
Why?
Consumer Behavior
1
1992
39
0.100
Why?
Pharmaceutical Services
1
1992
35
0.100
Why?
Aortic Valve
1
2015
444
0.100
Why?
Percutaneous Coronary Intervention
1
2016
233
0.100
Why?
Heart Failure
1
2025
2154
0.100
Why?
Observational Studies as Topic
2
2021
87
0.090
Why?
Managed Care Programs
2
2022
61
0.090
Why?
Global Health
2
2019
558
0.090
Why?
Patient Care Team
1
2015
545
0.090
Why?
Treatment Outcome
7
2021
12289
0.090
Why?
Achievement
1
2010
32
0.090
Why?
Adult
5
2024
29398
0.090
Why?
Health Personnel
1
2015
507
0.090
Why?
Aged, 80 and over
2
2020
6471
0.080
Why?
Patient Care
1
2010
100
0.080
Why?
Male
7
2024
61033
0.080
Why?
Health Care Surveys
1
2010
286
0.080
Why?
Clinical Decision-Making
2
2021
267
0.080
Why?
Medicare
2
2022
422
0.080
Why?
Program Evaluation
1
2010
449
0.080
Why?
Atrial Fibrillation
1
2015
637
0.070
Why?
Ambulatory Care Facilities
1
2010
227
0.070
Why?
Hospitals
1
2010
398
0.070
Why?
Triglycerides
1
2010
565
0.070
Why?
Randomized Controlled Trials as Topic
2
2021
1099
0.070
Why?
Comorbidity
2
2021
1514
0.060
Why?
Cholesterol, VLDL
1
2004
15
0.060
Why?
Quality Improvement
1
2010
641
0.060
Why?
Predictive Value of Tests
2
2021
2122
0.060
Why?
Stroke Volume
1
2025
449
0.050
Why?
Multimorbidity
1
2022
20
0.050
Why?
Medicaid
1
2024
243
0.050
Why?
United States Department of Defense
1
2021
10
0.050
Why?
Protective Factors
1
2021
84
0.050
Why?
Behavioral Risk Factor Surveillance System
1
2021
52
0.050
Why?
Drug Therapy, Combination
1
2024
1154
0.050
Why?
Pregnancy
2
2024
7167
0.050
Why?
Patient Care Management
1
2021
65
0.050
Why?
Committee Membership
1
2020
4
0.040
Why?
Cohort Studies
1
2010
4733
0.040
Why?
Blood Glucose
1
2024
1129
0.040
Why?
Drug Monitoring
1
2021
168
0.040
Why?
Databases, Factual
1
2024
1174
0.040
Why?
Aorta
1
2023
541
0.040
Why?
Hospitals, Teaching
1
2000
105
0.040
Why?
Recovery of Function
1
2021
441
0.040
Why?
Angina, Unstable
1
1998
52
0.040
Why?
Drug Prescriptions
2
2008
220
0.040
Why?
Angioplasty, Balloon, Coronary
1
2000
174
0.040
Why?
Thromboembolism
1
1998
88
0.040
Why?
Critical Pathways
1
2018
77
0.040
Why?
Prosthesis Design
1
2021
688
0.040
Why?
Sequestering Agents
1
2017
2
0.040
Why?
Heart Valve Prosthesis
1
2021
301
0.040
Why?
Forecasting
1
2019
351
0.040
Why?
United States Department of Veterans Affairs
1
2021
669
0.040
Why?
Chemoprevention
1
2017
57
0.030
Why?
Heparin
1
1998
228
0.030
Why?
Hemodynamics
1
2021
844
0.030
Why?
Drug-Eluting Stents
1
2016
55
0.030
Why?
Classification
1
2015
18
0.030
Why?
Enzyme Inhibitors
1
2017
578
0.030
Why?
Evidence-Based Practice
1
2015
114
0.030
Why?
Cooperative Behavior
1
2015
220
0.030
Why?
Morbidity
1
2014
244
0.030
Why?
Decision Support Techniques
1
2016
287
0.030
Why?
Cross-Sectional Studies
1
2021
3427
0.030
Why?
Incidence
1
2019
3086
0.020
Why?
Time Factors
1
2021
6273
0.020
Why?
Statistics, Nonparametric
1
2008
426
0.020
Why?
Chi-Square Distribution
1
2008
582
0.020
Why?
Guidelines as Topic
1
2006
198
0.010
Why?
Prognosis
1
2014
4553
0.010
Why?
Patient Discharge
1
2008
495
0.010
Why?
Adolescent
1
2021
19360
0.010
Why?
Logistic Models
1
2008
1804
0.010
Why?
Surveys and Questionnaires
1
1992
3735
0.010
Why?
Partial Thromboplastin Time
1
1998
46
0.010
Why?
Medical Records
1
1998
190
0.010
Why?
Hospital Costs
1
1998
178
0.010
Why?
Body Weight
1
1998
1005
0.010
Why?
Length of Stay
1
1998
1308
0.010
Why?
Severity of Illness Index
1
1998
2896
0.010
Why?
Texas
1
1998
3591
0.010
Why?
BIRTCHER's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (164)
Explore
_
Co-Authors (16)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_